| Attribute |
Value |
| 52 Week Change |
-0.1211499 |
| Address1 |
8-2-337, Road No. 3 |
| Address2 |
Banjara Hills |
| All Time High |
16.892 |
| All Time Low |
1.004 |
| Ask |
15.0 |
| Ask Size |
5,200 |
| Average Analyst Rating |
2.6 - Hold |
| Average Daily Volume10 Day |
3,060,410 |
| Average Daily Volume3 Month |
2,670,359 |
| Average Volume |
2,670,359 |
| Average Volume10Days |
3,060,410 |
| Beta |
0.259 |
| Bid |
0.0 |
| Bid Size |
3,800 |
| Book Value |
0.80166465 |
| City |
Hyderabad |
| Compensation As Of Epoch Date |
1,798,675,200 |
| Country |
India |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
12.84 |
| Current Ratio |
1.802 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,782,777,600 |
| Day High |
12.9 |
| Day Low |
12.7 |
| Debt To Equity |
20.328 |
| Display Name |
Dr. Reddy's Laboratories |
| Dividend Date |
1,754,438,400 |
| Dividend Rate |
0.08 |
| Dividend Yield |
0.65 |
| Earnings Call Timestamp End |
1,784,728,800 |
| Earnings Call Timestamp Start |
1,784,728,800 |
| Earnings Growth |
-0.862 |
| Earnings Quarterly Growth |
-0.862 |
| Earnings Timestamp |
1,784,723,400 |
| Earnings Timestamp End |
1,784,723,400 |
| Earnings Timestamp Start |
1,784,723,400 |
| Ebitda |
68,148,998,144 |
| Ebitda Margins |
0.20286 |
| Enterprise To Ebitda |
0.836 |
| Enterprise To Revenue |
0.17 |
| Enterprise Value |
56,943,501,312 |
| Eps Current Year |
51.04 |
| Eps Forward |
0.65751487 |
| Eps Trailing Twelve Months |
0.55 |
| Esg Populated |
0 |
| Ex Dividend Date |
1,783,555,200 |
| Exchange |
NYQ |
| Exchange Data Delayed By |
0 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fifty Day Average |
13.621 |
| Fifty Day Average Change |
-0.78100014 |
| Fifty Day Average Change Percent |
-0.057337943 |
| Fifty Two Week Change Percent |
-12.11499 |
| Fifty Two Week High |
15.67 |
| Fifty Two Week High Change |
-2.83 |
| Fifty Two Week High Change Percent |
-0.18059987 |
| Fifty Two Week Low |
12.19 |
| Fifty Two Week Low Change |
0.6500006 |
| Fifty Two Week Low Change Percent |
0.053322446 |
| Fifty Two Week Range |
12.19 - 15.67 |
| Financial Currency |
INR |
| First Trade Date Milliseconds |
986,995,800,000 |
| Five Year Avg Dividend Yield |
0.72 |
| Float Shares |
3,590,894,383 |
| Forward Eps |
0.65751487 |
| Forward P E |
19.528076 |
| Free Cashflow |
1,627,500,032 |
| Full Exchange Name |
NYSE |
| Full Time Employees |
27,527 |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Gross Margins |
0.52768004 |
| Gross Profits |
177,264,001,024 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.0 |
| Held Percent Institutions |
0.15232 |
| Implied Shares Outstanding |
832,710,225 |
| Industry |
Drug Manufacturers - Specialty & Generic |
| Industry Disp |
Drug Manufacturers - Specialty & Generic |
| Industry Key |
drug-manufacturers-specialty-generic |
| Is Earnings Date Estimate |
0 |
| Language |
en-US |
| Last Dividend Date |
1,753,401,600 |
| Last Dividend Value |
0.091 |
| Last Fiscal Year End |
1,774,915,200 |
| Last Split Date |
1,730,764,800 |
| Last Split Factor |
5:1 |
| Long Business Summary |
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. The company operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment. Its Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids with the customer requirements. Its Others segment engages in developing therapies in the fields of oncology and inflammation; and research, development, and commercialization of differentiated formulations. The company offers its products for various therapeutic categories, including gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology, vaccines, vitamins and minerals, and pain management. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India. |
| Long Name |
Dr. Reddy's Laboratories Limited |
| Market |
us_market |
| Market Cap |
10,691,998,720 |
| Market State |
PRE |
| Max Age |
86,400 |
| Message Board Id |
finmb_881725 |
| Most Recent Quarter |
1,774,915,200 |
| Net Income To Common |
42,850,000,896 |
| Next Fiscal Year End |
1,806,451,200 |
| Non Diluted Market Cap |
10,896,280,273 |
| Number Of Analyst Opinions |
5 |
| Open |
12.95 |
| Operating Cashflow |
56,754,999,296 |
| Operating Margins |
0.015420001 |
| Payout Ratio |
0.156 |
| Peg Ratio |
1.57 |
| Phone |
91 40 4900 2900 |
| Pre Market Change |
0.21000004 |
| Pre Market Change Percent |
1.6355143 |
| Pre Market Price |
13.05 |
| Pre Market Time |
1,784,114,598 |
| Previous Close |
12.92 |
| Price Eps Current Year |
0.2515674 |
| Price Hint |
2 |
| Price To Book |
16.016672 |
| Price To Sales Trailing12 Months |
0.03182777 |
| Profit Margins |
0.12755999 |
| Quick Ratio |
1.131 |
| Quote Source Name |
Delayed Quote |
| Quote Type |
EQUITY |
| Recommendation Key |
hold |
| Recommendation Mean |
2.6 |
| Region |
US |
| Regular Market Change |
-0.0799999 |
| Regular Market Change Percent |
-0.619194 |
| Regular Market Day High |
12.9 |
| Regular Market Day Low |
12.7 |
| Regular Market Day Range |
12.7 - 12.9 |
| Regular Market Open |
12.95 |
| Regular Market Previous Close |
12.92 |
| Regular Market Price |
12.84 |
| Regular Market Time |
1,784,059,202 |
| Regular Market Volume |
2,514,471 |
| Return On Assets |
0.05741 |
| Return On Equity |
0.11835 |
| Revenue Growth |
-0.116 |
| Revenue Per Share |
67.39318 |
| Sand P52 Week Change |
0.2043345 |
| Sector |
Healthcare |
| Sector Disp |
Healthcare |
| Sector Key |
healthcare |
| Shares Outstanding |
832,710,225 |
| Shares Percent Shares Out |
0.0278 |
| Shares Short |
23,186,031 |
| Shares Short Previous Month Date |
1,780,012,800 |
| Shares Short Prior Month |
22,387,669 |
| Short Name |
Dr. Reddy's Laboratories Ltd |
| Short Percent Of Float |
0.033800002 |
| Short Ratio |
9.73 |
| Source Interval |
15 |
| Symbol |
RDY |
| Target High Price |
16.911142 |
| Target Low Price |
11.304898 |
| Target Mean Price |
14.1852455 |
| Target Median Price |
13.860164 |
| Total Cash |
87,813,996,544 |
| Total Cash Per Share |
17.611 |
| Total Debt |
77,340,999,680 |
| Total Revenue |
335,933,014,016 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
8.0 |
| Trailing Annual Dividend Yield |
0.61919504 |
| Trailing Eps |
0.55 |
| Trailing P E |
23.345455 |
| Trailing Peg Ratio |
1.5409 |
| Triggerable |
1 |
| Two Hundred Day Average |
13.82 |
| Two Hundred Day Average Change |
-0.97999954 |
| Two Hundred Day Average Change Percent |
-0.07091169 |
| Type Disp |
Equity |
| Volume |
2,514,471 |
| Website |
https://www.drreddys.com |
| Zip |
500,034 |